- Report
- March 2025
- 192 Pages
Global
From €3386EUR$3,545USD£2,831GBP
€3762EUR$3,939USD£3,146GBP
- Report
- March 2025
- 93 Pages
Global
From €5348EUR$5,600USD£4,472GBP
- Report
- July 2024
- 175 Pages
Global
From €4775EUR$5,000USD£3,993GBP
- Report
- July 2024
- 100 Pages
Global
From €3581EUR$3,750USD£2,995GBP
- Report
- January 2025
- 200 Pages
Global
From €4770EUR$4,995USD£3,989GBP
- Report
- February 2024
- 175 Pages
Global
From €4298EUR$4,500USD£3,594GBP
- Report
- March 2024
- 200 Pages
Global
From €3963EUR$4,150USD£3,314GBP
- Report
- July 2023
- 95 Pages
Global
From €3500EUR$3,926USD£3,029GBP
Urolithiasis Management Devices are medical devices used to treat urolithiasis, a condition characterized by the presence of stones in the urinary tract. These devices are used to break up, remove, or prevent the formation of stones. Commonly used devices include lithotripters, ureteroscopes, and laser lithotripsy systems. Lithotripters use shock waves to break up stones, while ureteroscopes are used to locate and remove stones. Laser lithotripsy systems use laser energy to break up stones.
Urolithiasis Management Devices are used in a variety of settings, including hospitals, outpatient clinics, and private practices. They are used to treat a wide range of urolithiasis conditions, including kidney stones, bladder stones, and ureteral stones.
Some companies in the Urolithiasis Management Device market include Boston Scientific, Cook Medical, Olympus, Stryker, and Richard Wolf. Show Less Read more